ACADVL Gene - Very Long-Chain Acyl-CoA Dehydrogenase

Essential enzyme in mitochondrial fatty acid β-oxidation; mutations cause VLCAD deficiency

Gene Information Card

Symbol ACADVL
Full Name Acyl-CoA Dehydrogenase Very Long Chain
Gene Type Protein coding
Chromosomal Location 17p13.1
NCBI Gene ID 37 ncbi.nlm.nih.gov/gene/37
Ensembl ID ENSG00000072778
UniProt ID P49748
OMIM ID 609575
HGNC ID 92
Aliases VLCAD, ACAD6, LCACD

Description

The ACADVL gene encodes very long-chain acyl-CoA dehydrogenase (VLCAD), a mitochondrial enzyme that catalyzes the first step of mitochondrial fatty acid β-oxidation for long-chain fatty acids (14–20 carbons). VLCAD is a homodimer localized to the inner mitochondrial membrane. Mutations in ACADVL cause very long-chain acyl-CoA dehydrogenase deficiency (VLCADD), an autosomal recessive disorder of fatty acid oxidation presenting with hypoketotic hypoglycemia, cardiomyopathy, and rhabdomyolysis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) Loss-of-function mutations impair β-oxidation of long-chain fatty acids, leading to energy deficiency and toxic metabolite accumulation ClinVar, OMIM
Sudden infant death syndrome (SIDS) Severe neonatal VLCADD can present as sudden death; postmortem biochemical and genetic testing identifies ACADVL mutations NCBI, ClinVar
Cardiomyopathy, hypertrophic Accumulation of long-chain acylcarnitines in cardiac muscle due to defective oxidation causes hypertrophic cardiomyopathy OMIM, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Heart 15.2 High
Skeletal muscle 18.7 High
Kidney 8.3 Medium
Brain 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.0 Hepatocyte cell line
K-562 6.5 Lymphoblast cell line
SH-SY5Y 3.2 Neuroblastoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.848T>C (p.Val283Ala) Missense Common in European populations Reduced enzyme activity; mild phenotype
c.1040C>T (p.Thr347Met) Missense Rare Severe VLCADD; complete loss of function
c.1322G>A (p.Arg441Gln) Missense Found in compound heterozygotes Partial activity; late-onset myopathy
c.1844_1845delCT (p.Pro615Argfs*7) Frameshift Rare Null allele; severe neonatal form
Mutation functional classification

Loss of Function (LOF)

Most ACADVL mutations are loss-of-function, reducing or abolishing VLCAD enzyme activity, leading to impaired fatty acid oxidation and VLCADD.

Gain of Function (GOF)

No gain-of-function mutations reported for ACADVL.

Dominant Negative (DN)

No dominant-negative mutations reported; VLCADD is autosomal recessive.

Gene Ontology (GO)

• GO:0003995 - acyl-CoA dehydrogenase activity • GO:0005739 - mitochondrion
• GO:0016627 - oxidoreductase activity • acting on the CH-CH group of donors
• GO:0033539 - fatty acid beta-oxidation using acyl-CoA dehydrogenase • GO:0050660 - flavin adenine dinucleotide binding

Pathways

Mitochondrial fatty acid β-oxidation (Reactome: R-HSA-77289)
Fatty acid metabolism (KEGG: hsa00071)
PPAR signaling pathway (KEGG: hsa03320)

Protein Summary

VLCAD (UniProt P49748) is a 655-amino acid homodimeric mitochondrial enzyme that catalyzes the α,β-dehydrogenation of very long-chain acyl-CoAs (C14–C20). It contains a flavin adenine dinucleotide (FAD) cofactor and is anchored to the inner mitochondrial membrane. Defects cause VLCAD deficiency, a disorder of fatty acid oxidation with variable severity.

Related Products

Product name Cat.No. Species Gene ID
ACADVL Knockout HEK293 Cell Line EDJ-KQ3277 Human 37 Details Get a Quote
ACADVL Knockout A-549 Cell Line EDJ-KQ24828 Human 37 Details Get a Quote
ACADVL Knockout HCT 116 Cell Line EDJ-KQ24829 Human 37 Details Get a Quote
ACADVL Knockout HeLa Cell Line EDJ-KQ24830 Human 37 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: